Skip to main content
TNON
NASDAQ Industrial Applications And Services

Tenon Medical Q2 2026: Revenue Up 127%, But Going Concern Doubt and Material Weakness Persist

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$5.762
Mkt Cap
$2.959M
52W Low
$4.375
52W High
$60.9
52W Position info
32% above low
Off High info
91% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

TNON sits 32% above its 52-week low of $4.375 on light trading volume (0.3× avg).

Summary

Tenon Medical's Q2 2026 shows strong revenue growth but ongoing going concern doubt, a material weakness in controls, and a cash runway of less than 12 months.


Key Events · Earnings and Guidance · TNON

  • Going Concern Doubt

    Management states substantial doubt about the company's ability to continue as a going concern for one year. Cash of $1.677M plus $3.62M net proceeds from July 2026 offering is insufficient for 12 months.

  • Material Weakness in Controls

    Disclosure controls and procedures are not effective due to lack of segregation of duties, a material weakness in internal controls.

  • Revenue Growth

    Q2 2026 revenue of $1.279M, up 127% YoY; gross margin improved to 64% from 43%.

  • Convertible Notes and Derivative Liability

    $5.16M principal convertible notes due Sept 11, 2026, with conversion price of $5.4845. Derivative liability of $475K at June 30, 2026, with non-cash gain of $88K.


Analysis · TNON · Industrial Applications And Services

Tenon Medical reported Q2 2026 revenue of $1.279 million, up 127% year-over-year, but the company continues to burn cash and has only $1.677 million in cash as of June 30, 2026. Management states there is substantial doubt about the company's ability to continue as a going concern for one year. The company also disclosed a material weakness in internal controls due to lack of segregation of duties. The 10-Q confirms the 1-for-35 reverse stock split effective August 10, 2026, and notes the company regained compliance with Nasdaq's stockholders' equity rule on July 17, 2026, but must evidence compliance in the Q3 10-Q to avoid delisting.

At the time of this filing, TNON was trading at $5.76 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3M. The 52-week trading range was $4.38 to $60.90. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TNON - Latest Insights

TNON
Aug 13, 2026, 4:25 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.75
Real-time Price: $5.76 info
Change: +$0.0100 (+0.17%) info
Market Cap: $2.959M info
TNON
Aug 11, 2026, 6:17 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $6.00
Real-time Price: $5.76 info
Change: -$0.238 (-4%) info
Market Cap: $2.959M info
TNON
Aug 11, 2026, 5:30 PM EDT
Filing Type: S-3
Importance Score:
8
Price at Filing: $6.14
Real-time Price: $5.76 info
Change: -$0.378 (-6%) info
Market Cap: $2.959M info
TNON
Aug 10, 2026, 5:26 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.88
Real-time Price: $5.76 info
Change: Reverse Stock Split info
Market Cap: $2.959M info
TNON
Jul 24, 2026, 4:45 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.1898
Real-time Price: $5.76 info
Change: Reverse Stock Split info
Market Cap: $2.959M info